Lipoprotein(a). A unique risk factor for atherothrombotic disease.
1990; Volume: 10; Issue: 5 Linguagem: Inglês
10.1161/01.atv.10.5.672
ISSN2330-9180
Autores Tópico(s)Antiplatelet Therapy and Cardiovascular Diseases
ResumoHomeArteriosclerosis: An Official Journal of the American Heart Association, Inc.Vol. 10, No. 5Lipoprotein(a). A unique risk factor for atherothrombotic disease. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBLipoprotein(a). A unique risk factor for atherothrombotic disease. J Loscalzo J LoscalzoJ Loscalzo Center for Research in Thrombolysis, Lipid Clinic, Brigham and Women's Hospital, Boston, MA 02115. Originally published1 Sep 1990https://doi.org/10.1161/01.ATV.10.5.672Arteriosclerosis: An Official Journal of the American Heart Association, Inc.. 1990;10:672–679 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Utermann G (2023) 60 Years of Lp(a) Research: From Ouchterlonys Double Diffusion to Copy Number Variation and a Significant Risk Factor for CHD Lipoprotein(a), 10.1007/978-3-031-24575-6_1, (1-37), . Hishikari K, Hikita H, Yoshikawa H, Abe F, Tsujihata S, Ito N, Kanno Y, IIya M, Murai T, Takahashi A, Yonetsu T and Sasano T (2020) Usefulness of Lipoprotein (a) for Predicting Outcomes After Percutaneous Coronary Intervention for Stable Angina Pectoris in Patients on Hemodialysis, The American Journal of Cardiology, 10.1016/j.amjcard.2020.08.049, 136, (32-37), Online publication date: 1-Dec-2020. Dušejovská M, Vecka M, Rychlík I and Žák A (2020) Dyslipidemia in patients with chronic kidney disease: etiology and management, Vnitřní lékařství, 10.36290/vnl.2020.082, 66:5, (275-281), Online publication date: 1-Aug-2020. Fatahi S, Kord-Varkaneh H, Talaei S, Mardali F, Rahmani J, Ghaedi E, Tan S and Shidfar F (2019) Impact of phytosterol supplementation on plasma lipoprotein(a) and free fatty acid (FFA) concentrations: A systematic review and meta-analysis of randomized controlled trials, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2019.07.011, 29:11, (1168-1175), Online publication date: 1-Nov-2019. Gaddi A, Giovannini M, Cenni G, Tempesta S, Pinto A, Carnevali L and Capello F Comparative use of three different laboratory methods to investigate a paradigmatic case of severe genetic dysbetalipoproteinemia, Mediterranean Journal of Nutrition and Metabolism, 10.3233/MNM-180268, 12:3, (293-303) Mokhsin A, Mokhtar S, Mohd Ismail A, M Nor F, Shaari S, Nawawi H, Yusoff K, Abdul Rahman T and Hoh B (2018) Observational study of the status of coronary risk biomarkers among Negritos with metabolic syndrome in the east coast of Malaysia, BMJ Open, 10.1136/bmjopen-2018-021580, 8:12, (e021580), Online publication date: 1-Dec-2018. Rigamonti F, Carbone F, Montecucco F, Bonaventura A, Liberale L, Burger F, Roth A, Bertolotto M, Spinella G, Pane B, Palombo D, Pende A, Dallegri F, Mach F, Bertolini S and Pisciotta L (2018) Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis, European Journal of Clinical Investigation, 10.1111/eci.12888, 48:3, (e12888), Online publication date: 1-Mar-2018. Waldeyer C, Makarova N, Zeller T, Schnabel R, Brunner F, Jørgensen T, Linneberg A, Niiranen T, Salomaa V, Jousilahti P, Yarnell J, Ferrario M, Veronesi G, Brambilla P, Signorini S, Iacoviello L, Costanzo S, Giampaoli S, Palmieri L, Meisinger C, Thorand B, Kee F, Koenig W, Ojeda F, Kontto J, Landmesser U, Kuulasmaa K and Blankenberg S (2017) Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium, European Heart Journal, 10.1093/eurheartj/ehx166, 38:32, (2490-2498), Online publication date: 21-Aug-2017. Guzik A and Bushnell C (2017) Stroke Epidemiology and Risk Factor Management, CONTINUUM: Lifelong Learning in Neurology, 10.1212/CON.0000000000000416, 23:1, (15-39), Online publication date: 1-Feb-2017. Fan Y, Hu J, Guo F, Lu Z and Xia H (2017) Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease, Brazilian Journal of Medical and Biological Research, 10.1590/1414-431x20175979, 50:8 Kunutsor S, Khan H, Nyyssönen K and Laukkanen J (2016) Is lipoprotein (a) protective of dementia?, European Journal of Epidemiology, 10.1007/s10654-016-0184-0, 31:11, (1149-1152), Online publication date: 1-Nov-2016. Song Z, Cao H, Wu H, Zhou L and Qin L (2016) A Case-Control Study of the Relationship Between SLC22A3-LPAL2-LPA Gene Cluster Polymorphism and Coronary Artery Disease in the Han Chinese Population, Iranian Red Crescent Medical Journal, 10.5812/ircmj.35387, 18:6 Gohar A, Schnabel R, Hughes M, Zeller T, Blankenberg S, Pasterkamp G and den Ruijter H (2015) Underrepresentation of sex in reporting traditional and emerging biomarkers for primary prevention of cardiovascular disease: a systematic review, European Heart Journal - Quality of Care and Clinical Outcomes, 10.1093/ehjqcco/qcv028, 2:2, (99-107), Online publication date: 1-Apr-2016. Menaa F, Menaa B, Kahn B and Menaa A (2016) Trans Fats and Risks of Cardiovascular Diseases Handbook of Lipids in Human Function, 10.1016/B978-1-63067-036-8.00002-0, (21-38), . Reiss A, Voloshyna I, De Leon J, Miyawaki N and Mattana J (2015) Cholesterol Metabolism in CKD, American Journal of Kidney Diseases, 10.1053/j.ajkd.2015.06.028, 66:6, (1071-1082), Online publication date: 1-Dec-2015. Maor E, Fefer P, Varon D, Rosenberg N, Levi N, Hod H and Matetzky S (2015) Thrombophilic state in young patients with acute myocardial infarction, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-014-1166-2, 39:4, (474-480), Online publication date: 1-May-2015. Boztosun B and Acar R (2013) Treating thrombus in the coronary arteriesBehandlung eines Thrombus in den Koronararterien, Herz, 10.1007/s00059-013-3920-1, 40:1, (60-65), Online publication date: 1-Feb-2015. Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R, Sai E, Fukushima Y, Katoh Y, Okai I, Tamura H, Okazaki S and Daida H (2015) Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention, The American Journal of Cardiology, 10.1016/j.amjcard.2014.10.015, 115:2, (157-160), Online publication date: 1-Jan-2015. Wang F, Fu Y and Lv Z (2013) Association of Helicobacter pylori infection with diabetic complications: a meta-analysis , Endocrine Research, 10.3109/07435800.2013.794426, 39:1, (7-12), Online publication date: 1-Feb-2014. Kusunoki M, Tsutsumi K, Sato D, Miyata T and Nakamura T (2014) Effects of Fasting on Plasma Lipoprotein(a) in Cynomolgus Monkeys: Preliminary Experiments Results, Open Journal of Animal Sciences, 10.4236/ojas.2014.45028, 04:05, (222-227), . Wang F, Liu J and Lv Z (2013) Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: A meta-analysis of 39 studies involving more than 20,000 participants, Scandinavian Journal of Infectious Diseases, 10.3109/00365548.2013.844351, 45:12, (930-938), Online publication date: 1-Dec-2013. Kwon S, Lee B, Hong B, Kim J, Choi E, Sung J, Rhee J, Park Y, Ma D, Chung H, Mun H, Lee S, Park J, Min P, Yoon Y, Rim S and Kwon H (2013) Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients, International Journal of Cardiology, 10.1016/j.ijcard.2012.05.007, 167:5, (1990-1994), Online publication date: 1-Sep-2013. Menaa F, Menaa A, Menaa B and Tréton J (2012) Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France, European Journal of Nutrition, 10.1007/s00394-012-0484-4, 52:4, (1289-1302), Online publication date: 1-Jun-2013. P Phan B and Toth P (2017) Lipoprotein(a): epidemiology, atherogenic activity and impact on cardiovascular risk, Clinical Lipidology, 10.2217/clp.13.9, 8:2, (195-203), Online publication date: 1-Apr-2013. Capra V, Bäck M, Barbieri S, Camera M, Tremoli E and Rovati G (2012) Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke, Medicinal Research Reviews, 10.1002/med.21251, 33:2, (364-438), Online publication date: 1-Mar-2013. Malaguarnera M, Vacante M, Russo C, Malaguarnera G, Antic T, Malaguarnera L, Bella R, Pennisi G, Galvano F and Frigiola A (2013) Lipoprotein(a) in Cardiovascular Diseases, BioMed Research International, 10.1155/2013/650989, 2013, (1-9), . Dominiczak M and Caslake M (2011) Apolipoproteins: metabolic role and clinical biochemistry applications, Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 10.1258/acb.2011.011111, 48:6, (498-515), Online publication date: 1-Nov-2011. Fefer P, Butany J and Strauss B (2010) Pathology of Coronary Artery Disease Cardiovascular Interventions in Clinical Practice, 10.1002/9781444316704.ch26, (243-254) Arrobas T, Barco A, Rico M, de la Iglesia R, Oribe A, Cruz C and Fabiani F (2010) Influencia de la concentración de la lipoproteína(a) en la consecución de objetivos terapéuticos de colesterol LDL en pacientes de alto riesgo cardiovascular. Importancia del colesterol LDL corregido, Clínica e Investigación en Arteriosclerosis, 10.1016/S0214-9168(10)70002-4, 22:1, (7-14), Online publication date: 1-Jan-2010. Gurfinkel E, Vigliano C, Janavel J, Fornoni D, Caponi G, Meckert P, Bertolotti A, Favaloro R and Laguens R (2009) Presence of vulnerable coronary plaques in middle-aged individuals who suffered a brain death, European Heart Journal, 10.1093/eurheartj/ehp303, 30:23, (2845-2853), Online publication date: 1-Dec-2009. Khawaja F and Kullo I (2009) Novel markers of peripheral arterial disease, Vascular Medicine, 10.1177/1358863X09106869, 14:4, (381-392), Online publication date: 1-Nov-2009. zdl S, ahin S and Tokgzolu L (2008) Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a), International Journal of Dermatology, 10.1111/j.1365-4632.2008.03690.x, 47:8, (785-789), Online publication date: 1-Aug-2008. Kritchevsky D (2008) Fats and Oils in Human Health Food Lipids, 10.1201/9781420046649.pt4, Online publication date: 17-Mar-2008. Hamed S, Amine N, Galal G, Helal S, Tag El-Din L, Shawky O, Ahmed E and Abdel Rahman M (2008) Vascular Risks and Complications in Diabetes Mellitus: The Role of Helicobacter Pylori Infection, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2007.10.006, 17:2, (86-94), Online publication date: 1-Mar-2008. Chien K, Hsu H, Su T, Sung F, Chen M and Lee Y (2008) Lipoprotein(a) and Cardiovascular Disease in Ethnic Chinese: The Chin-Shan Community Cardiovascular Cohort Study, Clinical Chemistry, 10.1373/clinchem.2007.090969, 54:2, (285-291), Online publication date: 1-Feb-2008. Paraskevas K, Baker D, Vrentzos G and Mikhailidis D (2008) The role of fibrinogen and fibrinolysis in peripheral arterial disease, Thrombosis Research, 10.1016/j.thromres.2007.06.003, 122:1, (1-12), Online publication date: 1-Jan-2008. Mallika V, Goswami B and Rajappa M (2007) Atherosclerosis Pathophysiology and the Role of Novel Risk Factors: A Clinicobiochemical Perspective, Angiology, 10.1177/0003319707303443, 58:5, (513-522), Online publication date: 1-Oct-2007. BUYUKHATIPOGLU H, TIRYAKI O, TAHTA K and USALAN C (2007) Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: The role of chlamydia and cytomegalovirus infection, Nephrology, 10.1111/j.1440-1797.2006.00742.x, 12:1, (25-32), Online publication date: 1-Feb-2007. Williams D, Hagedorn J, Lawson E, Galanko J, Safadi B, Curet M and Morton J (2007) Gastric bypass reduces biochemical cardiac risk factors, Surgery for Obesity and Related Diseases, 10.1016/j.soard.2006.10.003, 3:1, (8-13), Online publication date: 1-Jan-2007. El-Gengaihy A, Abdelhadi S, Kirmani J and Qureshi A (2007) Thrombolytics Comprehensive Medicinal Chemistry II, 10.1016/B0-08-045044-X/00196-6, (763-781), . AMENGUAL O, ATSUMI T and KOIKE T (2006) Pathophysiology of the antiphospholipid syndrome: roles of anticardiolipin antibodies in thrombosis and fibrinolysis, APLAR Journal of Rheumatology, 10.1111/j.1479-8077.2006.00230.x, 9:4, (377-386), Online publication date: 1-Dec-2006. Bedarida G, Hoffmann U and Tatò F (2016) Acute lower limb ischemia due to thrombo-embolic arterial occlusions in two previously healthy men with markedly elevated Lp(a), Vascular Medicine, 10.1177/1358863x06072218, 11:4, (259-262), Online publication date: 1-Nov-2006. Rana J, Jansen A, Zwinderman A, van Aalst-Cohen E, Jukema J, Trip M and Kastelein J (2006) Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemia, Journal of Internal Medicine, 10.1111/j.1365-2796.2006.01670.x, 260:2, (183-185), Online publication date: 1-Aug-2006. Aras D, Geyik B, Topaloglu S, Ergun K, Ayaz S, Maden O, Yildiz A, Balci M, Ozeke O and Korkmaz S (2006) Serum level of lipoprotein (a) is inversely associated with the development of coronary collateral circulation, Coronary Artery Disease, 10.1097/00019501-200603000-00010, 17:2, (159-163), Online publication date: 1-Mar-2006. Menon D and Vongpatanasin W (2006) Effects of Transdermal Estrogen Replacement Therapy on Cardiovascular Risk Factors, Treatments in Endocrinology, 10.2165/00024677-200605010-00005, 5:1, (37-51), . Viles-Gonzalez J, Badimon J and Fuster V (2006) Pathogenesis of Atherosclerosis Antioxidants and Cardiovascular Disease, 10.1007/0-387-29553-4_3, (49-85), . Guven A, Inanc F, Kilinc M and Ekerbicer H (2005) Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome, Heart and Vessels, 10.1007/s00380-004-0822-4, 20:6, (290-295), Online publication date: 25-Nov-2005. Torres-Grate R, lvarez-Rodrguez E and Calvo Manuel E (2005) Historia natural de la arteriosclerosis. Expresividad cl?nica. Complicaciones agudas y cr?nicas, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 10.1016/S0211-3449(05)73755-3, 9:38, (2525-2535), Online publication date: 1-Sep-2005. Song K, Ko S, Kim H, Ahn Y, Lee J, Son H, Yoon K, Cha B, Lee K and Son H (2005) Prospective Study of Lipoprotein(a) as a Risk Factor for Deteriorating Renal Function in Type 2 Diabetic Patients With Overt Proteinuria, Diabetes Care, 10.2337/diacare.28.7.1718, 28:7, (1718-1723), Online publication date: 1-Jul-2005. IWAMOTO T, WATANABE D, UMAHARA T, SAKURAI H, HANYU H and KANAYA K (2004) Dual inverse effects of lipoprotein(a) on the dementia process in Japanese late-onset Alzheimer's disease, Psychogeriatrics, 10.1111/j.1479-8301.2004.00063.x, 4:3, (64-71), Online publication date: 1-Sep-2004. Knapp J and Herrmann W In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent, Clinical Chemistry and Laboratory Medicine (CCLM), 10.1515/CCLM.2004.205, 42:9 Yasuda S, Atsumi T, Ieko M and Koike T (2004) β2-glycoprotein I, anti-β2-glycoprotein I, and fibrinolysis, Thrombosis Research, 10.1016/j.thromres.2004.07.013, 114:5-6, (461-465), Online publication date: 1-Jan-2004. Ariyo A, Thach C and Tracy R (2003) Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly, New England Journal of Medicine, 10.1056/NEJMoa001066, 349:22, (2108-2115), Online publication date: 27-Nov-2003. DePalma R and Kowallek D (2003) Medical Management of Atherosclerotic Vascular Disease Vascular Surgery, 10.1201/9780203912904.pt2, Online publication date: 15-Oct-2003. Green D (2015) Thrombophilia and Stroke, Topics in Stroke Rehabilitation, 10.1310/L9KD-N5N8-69X0-08QK, 10:3, (21-33), Online publication date: 1-Oct-2003. Gazzaruso C, Garzaniti A, Falcone C, Puija A, Geroldi D, Giordanetti S and Fratino P (2003) Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients, Journal of Diabetes and its Complications, 10.1016/S1056-8727(02)00192-7, 17:3, (135-140), Online publication date: 1-May-2003. Malyszko J, Malyszko J and Mysliwiec M (2003) Fluvastin therapy affects TAFI concentration in kidney transplant recipients, Transplant International, 10.1111/j.1432-2277.2003.tb00223.x, 16:1, (53-57), Online publication date: 1-Jan-2003. Sambola A, Fuster V and José Badimon J (2003) Papel de los factores de riesgo en la trombogenicidad sanguínea y los síndromes coronarios agudos, Revista Española de Cardiología, 10.1016/S0300-8932(03)76998-X, 56:10, (1001-1009), Online publication date: 1-Jan-2003. Pedro-Botet J and Rubiés-Prat J (2003) Lipoproteína(a) y aterotrombosis, Clínica e Investigación en Arteriosclerosis, 10.1016/S0214-9168(03)78937-2, 15:6, (258-260), Online publication date: 1-Jan-2003. Galán M and Carlos Moreno J (2003) Alopecia androgenética y riesgo de enfermedad coronaria, Piel, 10.1016/S0213-9251(03)72670-7, 18:2, (61-62), Online publication date: 1-Jan-2003. Gazzaruso C, Garzaniti A, Falcone C, Geroldi D, Turpini C and Fratino P (2003) Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?, International Journal of Cardiology, 10.1016/S0167-5273(02)00202-4, 87:1, (91-98), Online publication date: 1-Jan-2003. (2003) Effect of Infection on Lipoproteins and the Coagulation System Infections and the Cardiovascular System: New Perspectives, 10.1007/0-306-47926-5_4, (91-117), . HRESKO M, MCDOUGALL P, GORLIN J, VAMVAKAS E, KASSER J and NEUFELD E (2002) PROSPECTIVE REEVALUATION OF THE ASSOCIATION BETWEEN THROMBOTIC DIATHESIS AND LEGG-PERTHES DISEASE, The Journal of Bone and Joint Surgery-American Volume, 10.2106/00004623-200209000-00014, 84:9, (1613-1618), Online publication date: 1-Sep-2002. Türner L, Serdaroǧlu A, Hasanoǧlu A, Biberoǧlu G and Aksoy E (2007) Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in epileptic children taking anticonvulsants, Acta Paediatrica, 10.1111/j.1651-2227.2002.tb02878.x, 91:9, (923-926) Luc G, Bard J, Arveiler D, Ferrieres J, Evans A, Amouyel P, Fruchart J and Ducimetiere P (2002) Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study, Atherosclerosis, 10.1016/S0021-9150(02)00026-6, 163:2, (377-384), Online publication date: 1-Aug-2002. Mutalib M, Khaza'ai H, Peace H, Whiting P and Wahle K (2002) Palm oil-enriched diets reduced plasma Lp(a) in volunteers with abnormally high concentrations: involvement of decreased triglyceride-rich APO(a), Nutrition Research, 10.1016/S0271-5317(02)00379-2, 22:7, (769-784), Online publication date: 1-Jul-2002. Morishita R, Sakaki M, Yamamoto K, Iguchi S, Aoki M, Yamasaki K, Matsumoto K, Nakamura T, Lawn R, Ogihara T and Kaneda Y (2002) Impairment of Collateral Formation in Lipoprotein(a) Transgenic Mice, Circulation, 105:12, (1491-1496), Online publication date: 26-Mar-2002. Fernández Ortiz A (2002) Role of Inflammatory Response and Thrombosis in Acute Coronary Syndromes Coronary Circulation and Myocardial Ischemia, 10.1007/978-3-642-57212-8_5, (46-61), . Ferns G and Lamb D (2001) Coronary heart disease: pathophysiological events and risk factors, Nutrition Bulletin, 10.1046/j.1467-3010.2001.00163.x, 26:3, (213-218), Online publication date: 1-Sep-2001. Walling A, Al-Dashti R and Tannenbaum C (2001) Hormone Replacement Therapy in Primary and Secondary Prevention of Coronary Artery Disease: Cardiologist and Geriatric Specialist Perspectives, Journal SOGC, 10.1016/S0849-5831(16)31442-2, 23:5, (409-416), Online publication date: 1-May-2001. Laskowska-Klita T, Szymczak E and Radomyska B (2016) Serum Homocysteine and Lipoprotein (a) Concentrations in Hypercholesterolemic and Normocholesterolemic Children, Clinical Pediatrics, 10.1177/000992280104000304, 40:3, (149-154), Online publication date: 1-Mar-2001. Dominiczak M Risk Factors for Coronary Disease: the Time for a Paradigm Shift?, Clinical Chemistry and Laboratory Medicine, 10.1515/CCLM.2001.147, 39:10 Matamoros P, Rubio M, Gutiérrez J and Fernández C (2001) Factores de riesgo cardiovascular la obesidad, Endocrinología y Nutrición, 10.1016/S1575-0922(01)74384-7, 48:6, (166-173), Online publication date: 1-Jan-2001. Evans R, Shpilberg O, Shaten B, Ali S, Kamboh M and Kuller L (2001) Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial, Journal of Clinical Epidemiology, 10.1016/S0895-4356(00)00260-2, 54:1, (51-57), Online publication date: 1-Jan-2001. Foody J, Milberg J, Pearce G and Sprecher D (2000) Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis, Atherosclerosis, 10.1016/S0021-9150(00)00427-5, 153:2, (445-451), Online publication date: 1-Dec-2000. Pati U and Pati N (2000) Lipoprotein(a), Atherosclerosis, and Apolipoprotein(a) Gene Polymorphism, Molecular Genetics and Metabolism, 10.1006/mgme.2000.3070, 71:1-2, (87-92), Online publication date: 1-Sep-2000. Bremner W, Sothern R, Kanabrocki E, Ryan M, McCormick J, Dawson S, Connors E, Rothschild R, Third J, Vahed S, Nemchausky B, Shirazi P and Olwin J (2000) Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men, American Heart Journal, 10.1016/S0002-8703(00)90324-7, 139:1, (164-173), Online publication date: 1-Jan-2000. Gallo R and Fuster V (2000) Pathogenesis of Atherosclerosis Antioxidants and Cardiovascular Disease, 10.1007/978-94-011-4375-2_2, (19-46), . Huber K and Kaindl F (2000) Pathophysiological Basis of the Acute Coronary Syndromes Textbook of Angiology, 10.1007/978-1-4612-1190-7_12, (162-170), . Bini A, Mann K, Kudryk B and Schoen F (1999) Noncollagenous Bone Matrix Proteins, Calcification, and Thrombosis in Carotid Artery Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, 19:8, (1852-1861), Online publication date: 1-Aug-1999. Hajjar K and Krishnan S (1999) Annexin II, Trends in Cardiovascular Medicine, 10.1016/S1050-1738(99)00020-1, 9:5, (128-138), Online publication date: 1-Jul-1999. Sasmaz S, Senol M, Ozcan A, Dogan G, Tuncer C, Akyol O and Sener S (1999) The risk of coronary heart disease in men with androgenetic alopecia, Journal of the European Academy of Dermatology and Venereology, 10.1111/j.1468-3083.1999.tb01001.x, 12:2, (123-125), Online publication date: 1-Mar-1999. Adamkiewicz M, Zgliczyńki S, Słowińska-Srzednicka J, Pietrzyk E, Rabijewski M, Srzednicki M, Gardas A and Sadowski Z (2009) The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone) and coronary arteriosclerosis in men: The lower the androgens, the higher the coronary score of arteriosclerosis, The Aging Male, 10.3109/13685539909003180, 2:1, (22-32), Online publication date: 1-Jan-1999. AONO H, ITO M, OZAWA H, WAKI T, MAGARI Y, Castro BELLO M and German RODORIGUEZ A (1999) Lipoprotein(a) Concentrations in Healthy Subjects in the Dominican Republic. Comparison with Japanese., Japanese Heart Journal, 10.1536/jhj.40.65, 40:1, (65-70), . Retzinger G, DeAnglis A and Patuto S (1998) Adsorption of Fibrinogen to Droplets of Liquid Hydrophobic Phases , Arteriosclerosis, Thrombosis, and Vascular Biology, 18:12, (1948-1957), Online publication date: 1-Dec-1998. Knopp R (1998) Clinical profiles of plain versus sustained-release niacin (niaspan) and the physiologic rationale for nighttime dosing, The American Journal of Cardiology, 10.1016/S0002-9149(98)00847-9, 82:12, (24U-28U), Online publication date: 1-Dec-1998. Capuzzi D, Guyton J, Morgan J, Goldberg A, Kreisberg R, Brusco O and Brody J (1998) Efficacy and safety of an extended-release niacin (niaspan): a long-term study, The American Journal of Cardiology, 10.1016/S0002-9149(98)00731-0, 82:12, (74U-81U), Online publication date: 1-Dec-1998. Morishita R, Yamada S, Yamamoto K, Tomita N, Kida I, Sakurabayashi I, Kikuchi A, Kaneda Y, Lawn R, Higaki J and Ogihara T (1998) Novel Therapeutic Strategy for Atherosclerosis , Circulation, 98:18, (1898-1904), Online publication date: 3-Nov-1998. Huber K, Nikfardjam M, Christ G, Gottsauner-Wolf M, Müllner M and Gulba D (1998) Acute coronary syndromes: recent achievements and future aspects, Fibrinolysis and Proteolysis, 10.1016/S0268-9499(98)80308-1, 12, (67-89), Online publication date: 1-Sep-1998. Morishita R, Yamada S, Higaki J, Tomita N, Kida I, Aoki M, Moriguchi A, Hayashi S, Sakurabayashi I, Kaneda Y and Ogihara T (1998) Conditioned Medium From HepG2 Cells Transfected With Human Apolipoprotein(a) Gene Stimulates Growth of Human Vascular Smooth Muscle Cells , Hypertension, 32:2, (215-222), Online publication date: 1-Aug-1998. Morishita R, Yamamoto K, Yamada S, Matsushita H, Tomita N, Sakurabayashi I, Kaneda Y, Moriguchi A, Higaki J and Ogihara T (1998) Stimulatory Effect of Lipoprotein (a) on Proliferation of Human Mesangial Cells: Role of Lipoprotein (a) in Renal Disease, Biochemical and Biophysical Research Communications, 10.1006/bbrc.1998.9116, 249:2, (313-320), Online publication date: 1-Aug-1998. Ballantyne C (1998) Current thinking in lipid lowering, The American Journal of Medicine, 10.1016/S0002-9343(98)00186-7, 104:6, (33S-41S), Online publication date: 1-Jun-1998. Sönmez H, Süer S, Ulutin T, Kökoglu E and Uçişik N (2016) The Relationship of Various Factors in the Pathogenesis of Atherosclerosis, Clinical and Applied Thrombosis/Hemostasis, 10.1177/107602969800400205, 4:2, (105-110), Online publication date: 1-Apr-1998. Matsumoto Y, Daida H, Watanabe Y, Sunayama S, Mokuno H, Yokoi H and Yamaguchi H (1998) High Level of Lipoprotein (a) is a Strong Predictor for Progression of Coronary Artery Disease, Journal of Atherosclerosis and Thrombosis, 10.5551/jat1994.5.47, 5:2, (47-53), . Gotto A (1998) Perspectives on Lipid-Lowering Therapy: Past and Present Multiple Risk Factors in Cardiovascular Disease, 10.1007/978-94-011-5022-4_4, (25-33), . Bilimoria M and Jordan V (1998) The duration of adjuvant tamoxifen therapy Biological and Hormonal Therapies of Cancer, 10.1007/978-1-4615-6189-7_10, (181-193), . Giri S, Waters D and Wu A (1998) Pathophysiology of Acute Coronary Syndromes Cardiac Markers, 10.1007/978-1-4612-1806-7_2, (21-44), . Braunwald E (1997) Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities, New England Journal of Medicine, 10.1056/NEJM199711063371906, 337:19, (1360-1369), Online publication date: 6-Nov-1997. Meckel C, Anderson T, Mudge G, Mitchell R, Yeung A, Selwyn A, Ganz P and Simon D (2016) Hemostatic/Fibrinolytic Predictors of Allograft Coronary Artery Disease after Cardiac Transplantation, Vascular Medicine, 10.1177/1358863X9700200406, 2:4, (306-312), Online publication date: 1-Nov-1997. MACKINNON L, HUBINGER L and LEPRE F (1997) Effects of physical activity and diet on lipoprotein(a), Medicine &Science in Sports &Exercise, 10.1097/00005768-199711000-00007, 29:11, (1429-1436), Online publication date: 1-Nov-1997. Huber K, Gulba D and Kaindi F (1997) Acute coronary syndromes and their pathophysiological basis, Fibrinolysis and Proteolysis, 10.1016/S0268-9499(97)80063-X, 11, (1-9), Online publication date: 1-Aug-1997. Gazzaruso C, Buscaglia P, Garzaniti A, Falcone C, Mariotti S, Savino S, Bonetti G, Finardi G and Geroldi D (1997) Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension, Journal of Hypertension, 10.1097/00004872-199715030-00003, 15:3, (227-235), Online publication date: 1-Mar-1997. Evans R, Bunker C, Ukoli F and Kuller L (2010) Lipoprotein (a) distribution in a Nigerian population, Ethnicity & Health, 10.1080/13557858.1997.9961814, 2:1-2, (47-58), Online publication date: 1-Mar-1997. Bonen D, Hausman A, Hadjiagapiou C, Skarosi S and Davidson N (1997) Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells, Journal of Biological Chemistry, 10.1074/jbc.272.9.5659, 272:9, (5659-5667), Online publication date: 1-Feb-1997. Evans R, Sankey S, Hauth B, Sutton-Tyrrell K, Kambon M and Kuller L (1996) Effect of sample storage on quantitation of lipoprotein (a) by an enzyme-linked immunosorbent assay, Lipids, 10.1007/BF02524295, 31:11, (1197-1203), Online publication date: 1-Nov-1996. Sunayama S, Daida H, Mokuno H, Miyano H, Yokoi H, Lee Y, Sakurai H and Yamaguchi H (1996) Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women ≥55 Years of Age, Circulation, 94:6, (1263-1268), Online publication date: 15-Sep-1996.Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S and Sirtori C (1996) Plasma Lipoprotein(a) Is an Independent Factor Associated With Carotid Wall Thickening in Severely but Not Moderately Hypercholesterolemic Patients, Stroke, 27:6, (1044-1049), Online publication date: 1-Jun-1996. HUBINGER L and MACKINNON L (1996) The effect of endurance training on lipoprotein(a) [Lp(a)] levels in middle-aged males, Medicine &Science in Sports &Exercise, 10.1097/00005768-199606000-00015, 28:6, (757-764), Online publication date: 1-Jun-1996. Pasternak R, Grundy S, Levy D and Thompson P (1996) Task force 3. Spectrum of risk factors for coronary heart disease, Journal of the American College of Cardiology, 10.1016/0735-1097(96)87731-X, 27:5, (978-990), Online publication date: 1-Apr-1996. Sutton-Tyrrell K, Evans R, Meilahn E and Alcorn H (1996) Lipoprotein(a) and peripheral atherosclerosis in older adults, Atherosclerosis, 10.1016/0021-9150(95)05734-X, 122:1, (11-19), Online publication date: 1-Apr-1996. Pauletto P, Puato M, Angeli M, Pessina A, Munhambo A, Bittolo-Bon G and Galli C (1996) Blood pressure, serum lipids, and fatty acids in populations on a lake-fish diet or on a vegetarian diet in Tanzania, Lipids, 10.1007/BF02637098, 31:1, (S309-S312), Online publication date: 1-Mar-1996. Fernández-Ortiz A and Fuster V (1996) Pathophysiology of Coronary Artery Disease, Clinics
Referência(s)